[go: up one dir, main page]

NO20021094D0 - Profylaktiske og terapeutiske medikamenter for oftalmologiske sykdommer - Google Patents

Profylaktiske og terapeutiske medikamenter for oftalmologiske sykdommer

Info

Publication number
NO20021094D0
NO20021094D0 NO20021094A NO20021094A NO20021094D0 NO 20021094 D0 NO20021094 D0 NO 20021094D0 NO 20021094 A NO20021094 A NO 20021094A NO 20021094 A NO20021094 A NO 20021094A NO 20021094 D0 NO20021094 D0 NO 20021094D0
Authority
NO
Norway
Prior art keywords
prophylactic
therapeutic drugs
ophthalmic diseases
ophthalmic
diseases
Prior art date
Application number
NO20021094A
Other languages
English (en)
Other versions
NO20021094L (no
Inventor
Hiroaki Naka
Kazuhito Kawabata
Hideki Tokushige
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of NO20021094D0 publication Critical patent/NO20021094D0/no
Publication of NO20021094L publication Critical patent/NO20021094L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20021094A 1999-09-06 2002-03-05 Profylaktiske og terapeutiske medikamenter for oftalmologiske sykdommer NO20021094L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25153899 1999-09-06
PCT/JP2000/006014 WO2001017527A1 (en) 1999-09-06 2000-09-05 Preventive and therapeutic agents for eye diseases

Publications (2)

Publication Number Publication Date
NO20021094D0 true NO20021094D0 (no) 2002-03-05
NO20021094L NO20021094L (no) 2002-05-06

Family

ID=17224318

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021094A NO20021094L (no) 1999-09-06 2002-03-05 Profylaktiske og terapeutiske medikamenter for oftalmologiske sykdommer

Country Status (14)

Country Link
US (1) US6624193B1 (no)
EP (1) EP1213018A4 (no)
JP (1) JP4682495B2 (no)
KR (1) KR20020042667A (no)
CN (1) CN1387436A (no)
AU (1) AU6870800A (no)
BR (1) BR0013793A (no)
CA (1) CA2383971A1 (no)
HU (1) HUP0202745A2 (no)
MX (1) MXPA02002452A (no)
NO (1) NO20021094L (no)
NZ (1) NZ517556A (no)
WO (1) WO2001017527A1 (no)
ZA (1) ZA200201819B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6552082B2 (en) * 2000-06-29 2003-04-22 Ono Pharmaceutical Co., Ltd. Solution of N-[o-(p-pivaloyloxybenzenesulfonylamino)benzoyl] glycine monosodium salt tetra-hydrate and drug product thereof
US20030195179A1 (en) * 2000-08-25 2003-10-16 Shirou Sawa Aqueous suspension preparations
US7315848B2 (en) * 2001-12-12 2008-01-01 Aaron Pearse Web snippets capture, storage and retrieval system and method
DE122011100019I1 (de) 2003-01-21 2011-11-03 Senju Pharma Co Wassrige flussige zubereitung mit 2-amino-3-(4-bromobenzoyl) phenylessigsaure.
EP1591110B1 (en) * 2003-01-22 2015-03-18 Senju Pharmaceutical Co., Ltd. Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye
US8372814B2 (en) * 2004-06-07 2013-02-12 Ista Pharmaceuticals, Inc. Ophthalmic formulations and uses thereof
US8748402B2 (en) 2004-06-07 2014-06-10 Bausch & Lomb Pharma Holdings Corp. Ophthalmic formulations and uses thereof
US20070208058A1 (en) * 2004-10-25 2007-09-06 Bryant Roy W Stable Pharmaceutical Compositions and Methods of Making and Using Same
KR20070104912A (ko) * 2005-02-17 2007-10-29 센주 세이야꾸 가부시키가이샤 안과용 고형 외용약제
HUE033597T2 (hu) 2006-09-29 2017-12-28 Johnson & Johnson Vision Care Eljárás allergia elleni szert tartalmazó szemészeti eszköz oxidációjának megelõzésére
MX2009011801A (es) * 2007-05-04 2009-11-13 Baush & Lomb Inc Composiciones para reducir, aminorar, tratar o evitar afeccion de ojo seco y metodos para elaboracion y uso de las mismas.
US20080280853A1 (en) * 2007-05-07 2008-11-13 Erning Xia Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
US8300252B2 (en) * 2008-06-18 2012-10-30 Livescribe, Inc. Managing objects with varying and repeated printed positioning information
TW201023912A (en) * 2008-12-05 2010-07-01 Alcon Res Ltd Pharmaceutical suspension
US8912236B2 (en) * 2009-03-03 2014-12-16 Alcon Research, Ltd. Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye
WO2010101971A1 (en) * 2009-03-03 2010-09-10 Alcon Research, Ltd. Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye
CN105142686B (zh) 2013-03-14 2020-04-10 帕恩欧普佳有限公司 给药于眼后段的眼用制剂
CA2989341C (en) * 2015-06-16 2021-12-07 Rong-Tsun Wu Method for treating or preventing dry eyes
JP2020525416A (ja) * 2017-06-29 2020-08-27 アドヴァイテ エルエルシー． 眼表面障害の治療及び診断

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340191C (en) 1988-06-13 1998-12-15 Katsuhiro Imaki Derivatives of p-substituted phenyl ester of pivalic acid
JPH0320253A (ja) * 1988-06-13 1991-01-29 Ono Pharmaceut Co Ltd ピバル酸　ｐ―置換フェニルエステル誘導体、それらの製造方法およびそれらを有効成分として含有するエラスターゼ阻害剤
WO1990004409A1 (en) 1988-10-27 1990-05-03 University Of Kentucky Research Foundation Human leukocyte elastase inhibitors and methods of producing and using same
ATE161016T1 (de) 1991-06-18 1997-12-15 Fujisawa Pharmaceutical Co Ws7622a enthaltende prophylaktische/therapeutische zusammensetzung zur vorbeugung und behandlung von verstreuter, intravaskulärer koagulation, chronischer, infektiöser atemwegskrankheiten oder chronischer bronchitis
GB9115811D0 (en) 1991-07-22 1991-09-04 Fujisawa Pharmaceutical Co Fr901451 substance,process for preparation thereof and use thereof
JPH05194366A (ja) * 1991-10-25 1993-08-03 Ono Pharmaceut Co Ltd グリシン誘導体・モノナトリウム塩・４水和物、その製造方法、それを含有する薬剤および該誘導体の中間体の製造方法
CA2081268A1 (en) 1991-10-25 1993-04-26 Katsuhiro Imaki Glycine derivative monosodium salt tetrahydrate

Also Published As

Publication number Publication date
AU6870800A (en) 2001-04-10
HUP0202745A2 (hu) 2003-01-28
ZA200201819B (en) 2003-05-28
JP4682495B2 (ja) 2011-05-11
MXPA02002452A (es) 2004-09-10
NO20021094L (no) 2002-05-06
EP1213018A1 (en) 2002-06-12
EP1213018A4 (en) 2004-04-14
CN1387436A (zh) 2002-12-25
NZ517556A (en) 2003-08-29
US6624193B1 (en) 2003-09-23
WO2001017527A1 (en) 2001-03-15
KR20020042667A (ko) 2002-06-05
WO2001017527A9 (fr) 2001-06-21
CA2383971A1 (en) 2001-03-15
BR0013793A (pt) 2002-05-14

Similar Documents

Publication Publication Date Title
NO20021094D0 (no) Profylaktiske og terapeutiske medikamenter for oftalmologiske sykdommer
DK1221919T3 (da) Oftalmisk lægemiddeladministrationsanordning
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
AU1227302A (en) System and method for optimizing drug therapy for the treatment of diseases
IS5500A (is) Lyfjablöndur til öftrunar og meðferðar mýlildi ogtengdum sjúkdómum
NO20021400D0 (no) Terapeutiske konazolinderivater
DK1637127T3 (da) Terapeutisk mikroskum
NO20015888L (no) Implanterbart gelpreparat og fremgangsmåter for fremstilling derav
NO20002831D0 (no) Medikament i myk tablettform og fremgangsmÕter for fremstilling av dette
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
NO20010556L (no) Fremgangsmate for oftalmisk administrering
NO994014D0 (no) Arylsulfonamider og analoger derav og deres anvendelse for behandling av neurodegenerative sykdommer
DK1161434T3 (da) Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
NO20014617L (no) 1-Arensulfonyl-2-aryl-pyrrolidin- og -piperidin-derivater for behandling av CNS-sykdommer
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
NO20023448D0 (no) Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin
DE69618560D1 (de) Medikament gegen ophthalmische erkrankungen
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
NO20033120D0 (no) 2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
NO20031656D0 (no) Kombinasjon omfattende camptothecin og et stillbenderivat for behandling avcancer
AU2000275035A1 (en) Therapeutic and prophylactic drugs of myopia
DK1372665T3 (da) Hormonerstatningsbehandling og administration
NO20026148D0 (no) Medisiner for forhindring og behandling av neurodegenerative sykdommer
EP1457210A4 (en) MEDICINE FOR THE TREATMENT AND / OR PREVENTION OF CONFORMATIONAL DISEASES
GB0225502D0 (en) Therapeutic and prophylactic preparations

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application